-
公开(公告)号:US08648100B2
公开(公告)日:2014-02-11
申请号:US11918397
申请日:2006-04-12
申请人: Rolf Beume , Armin Hatzelmann , Degenhard Marx , Christian Schudt , Hermann Tenor , Saadia Eddahibi , Serge Adnot
发明人: Rolf Beume , Armin Hatzelmann , Degenhard Marx , Christian Schudt , Hermann Tenor , Saadia Eddahibi , Serge Adnot
IPC分类号: A61K31/44 , C07D213/74
CPC分类号: A61K31/4412 , A61K31/44 , A61K31/4985 , A61K31/5025 , A61K31/506 , A61K31/519 , A61K31/53
摘要: The invention relates to the use of Roflumilast, Roflumilast N-Oxide or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. The invention additionally relates to the use of Roflumilast, Roflumilast N-oxide or a pharmaceutically acceptable salt of either in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the treatment of pulmonary hypertension.
摘要翻译: 本发明涉及罗氟司特,罗氟司特N-氧化物或其药学上可接受的盐用于治疗肺动脉高压的用途。 本发明还涉及Roflumilast,Roflumilast N-氧化物或其药学上可接受的盐与PDE5抑制剂或其药学上可接受的盐的组合用于治疗肺动脉高压的用途。
-
公开(公告)号:US20090215836A1
公开(公告)日:2009-08-27
申请号:US11918397
申请日:2006-04-12
申请人: Rolf Beume , Armin Hatzelmann , Degenhard Marx , Christian Schudt , Hermann Tenor , Saadia Eddahibi , Serge Adnot
发明人: Rolf Beume , Armin Hatzelmann , Degenhard Marx , Christian Schudt , Hermann Tenor , Saadia Eddahibi , Serge Adnot
CPC分类号: A61K31/4412 , A61K31/44 , A61K31/4985 , A61K31/5025 , A61K31/506 , A61K31/519 , A61K31/53
摘要: The invention relates to the use of Roflumilast, Roflumilast N-Oxide or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. The invention additionally relates to the use of Roflumilast, Roflumilast N-oxide or a pharmaceutically acceptable salt of either in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the treatment of pulmonary hypertension.
摘要翻译: 本发明涉及罗氟司特,罗氟司特N-氧化物或其药学上可接受的盐用于治疗肺动脉高压的用途。 本发明还涉及Roflumilast,Roflumilast N-氧化物或其药学上可接受的盐与PDE5抑制剂或其药学上可接受的盐的组合用于治疗肺动脉高压的用途。
-